国际肿瘤学杂志››2019,Vol. 46››Issue (1): 36-39.doi:10.3760/cma.j.issn.1673-422X.2019.01.008
吕天鑫,张兵雷,宋永平
收稿日期:
2018-08-31出版日期:
2019-01-08发布日期:
2019-04-03通讯作者:
宋永平 E-mail:songyongping001@126.comLyu Tianxin, Zhang Binglei, Song Yongping
Received:
2018-08-31Online:
2019-01-08Published:
2019-04-03Contact:
Song Yongping E-mail:songyongping001@126.com摘要:支链氨基酸转移酶1(BCAT1)作为催化支链氨基酸代谢的关键酶,参与多种生物合成的通路。研究发现BCAT1在白血病、胶质瘤、鼻咽癌、胃癌、乳腺癌等恶性肿瘤中高表达,与肿瘤细胞的增殖、侵袭及转移密切相关,在肿瘤的发生发展中扮演重要角色,可作为恶性肿瘤新的治疗靶点。
吕天鑫,张兵雷,宋永平. 支链氨基酸转移酶1与恶性肿瘤[J]. 国际肿瘤学杂志, 2019, 46(1): 36-39.
Lyu Tianxin, Zhang Binglei, Song Yongping. Branched chain amino acid transferase 1 and malignant tumors[J]. Journal of International Oncology, 2019, 46(1): 36-39.
[1] Papathanassiu AE, Ko JH, Imprialou M, et al. BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases[J]. Nat Commun, 2017, 8: 16040. DOI: 10.1038/ncomms16040. [2] 赖爱军, 谢斌辉. BCAT1促进肿瘤发生发展的研究进展[J]. 世界华人消化杂志, 2017, 25(17): 1536-1542. DOI: 10.11569/wcjd.v25.i17.1536. [3] 钟巧玉, 陈懿建. 成人急性髓系白血病靶向治疗的研究进展[J]. 临床合理用药杂志, 2018, 11(25): 175-178. DOI: 10.15887/j. cnki.131389/r.2018.25.100. [4] Ananieva EA, Wilkinson AC. Branchedchain amino acid metabolism in cancer[J]. Curr Opin Clin Nutr Metab Care, 2018, 21(1): 64-70. DOI: 10.1097/MCO.0000000000000430. [5] Raffel S, Falcone M, Kneisel N, et al. BCAT1 restricts αKG levels in AML stem cells leading to IDHmutlike DNA hypermethylation[J]. Nature, 2017, 551(7680): 384-388. DOI: 10.1038/nature24294. [6] Kaelin WG Jr, McKnight SL. Influence of metabolism on epigenetics and disease[J]. Cell, 2013, 153(1): 5669. DOI: 10.1016/j.cell.2013.03.004. [7] Wang P, Wu J, Ma S, et al. Oncometabolite D2hydroxyglutarate inhibits ALKBH DNA repair enzymes and sensitizes IDH mutant cells to alkylating agents[J]. Cell Rep, 2015, 13(11): 2353-2361. DOI: 10.1016/j.celrep.2015.11.029. [8] Marcucci G, Maharry K, Wu YZ, et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study[J]. J Clin Oncol, 2010, 28(14): 2348-2355. DOI: 10.1200/JCO.2009.27.3730. [9] Cancer Genome Atlas Research Network, Ley TJ, Miller C, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia[J]. N Engl J Med, 2013, 368(22): 2059-2074. DOI: 10.1056/NEJMoa1301689. [10] Ng SW, Mitchell A, Kennedy JA, et al. A 17gene stemness score for rapid determination of risk in acute leukaemia[J]. Nature, 2016, 540(7633): 433-437. DOI: 10.1038/nature20598. [11] Hattori A, Tsunoda M, Konuma T, et al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia[J]. Nature, 2017, 545(7655): 500-504. DOI: 10.1038/nature22314. [12] 中华医学会血液学分会. 中国慢性髓性白血病诊断与治疗指南(2013年版)[J]. 中华血液学杂志, 2013, 34(5): 464-470. DOI: 10.3760/cma.j.issn.0253-2727.2013.05.021. [13] Sutherland JM, McLaughlin EA, Hime GR, et al. The Musashi family of RNA binding proteins: master regulators of multiple stem cell populations[J]. Adv Exp Med Biol, 2013, 786: 233-245. DOI: 10.1007/978-94-007-6621-1_13. [14] Rentas S, Holzapfel N, Belew MS, et al. Musashi2 attenuates AHR signalling to expand human haematopoietic stem cells[J]. Nature, 2016, 532(7600): 508-511. DOI: 10.1038/nature17665. [15] 阙丽萍, 黄科. 儿童急性淋巴细胞白血病复发机制的研究进展[J]. 中国小儿血液与肿瘤杂志, 2016, 21(6): 322-326. DOI: 10.3969/j.issn.1673-5323.2016.06.010. [16] 李琴, 李晓明, 邢宏运. 成人急性淋巴细胞白血病发病机制研究进展[J]. 临床合理用药杂志, 2017, 10(22): 177-178. DOI: 10.15887/j.cnki.13-1389/r.2017.22.105. [17] Safavi S, Hansson M, Karlsson K, et al. Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia[J]. Haematologica, 2015, 100(1): 55-61. DOI: 10.3324/haematol.2014.112912. [18] Tnjes M, Barbus S, Park YJ, et al. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wildtype IDH1[J]. Nat Med, 2013, 19(7): 901-908. DOI: 10.1038/nm. 3217. [19] Zhou W, Feng X, Li H, et al. Functional evidence for a nasopharyngeal carcinomarelated gene BCAT1 located at 12pl2[J]. Oncol Res, 2007, 16(9): 405413. [20] Zhou W, Feng X, Ren C, et al. Overexpression of BCAT1, a cMyc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma[J]. Mol Cancer, 2013, 12: 53. DOI: 10.1186/147645981253. [21] Xu Y, Yu W, Yang T, et al. Overexpression of BCAT1 is a prognostic marker in gastric cancer[J]. Hum Pathol, 2018, 75: 41-46. DOI: 10.1016/j.humpath.2018.02.003. [22] Thewes V, Simon R, Hlevnjak M, et al. The branchedchain amino acid transaminase 1 sustains growth of antiestrogenresistant and ERαnegative breast cancer[J]. Oncogene, 2017, 36(29): 4124-4134. DOI: 10.1038/onc.2017.32. [23] Zhang L, Han J. Branchedchain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTORmediated mitochondrial biogenesis and function[J]. Biochem Biophys Res Commun, 2017, 486(2): 224-231. DOI: 10.1016/j.bbrc.2017.02.101. [24] Oktyabri D, Ishimura A, Tange S, et al. DOT1L histone methyltransferase regulates the expression of BCAT1 and is involved in sphere formation and cell migration of breast cancer cell lines[J]. Biochimie, 2016, 123: 20-31. DOI: 10.1016/j.biochi.2016.01.005. [25] Wang ZQ, Faddaoui A, Bachvarova M, et al. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism[J]. Oncotarget, 2015, 6(31): 31522-31543. DOI: 10.18632/oncotarget.5159. [26] Mayers JR, Torrence ME, Danai LV, et al. Tissue of origin dictates branchedchain amino acid metabolism in mutant Krasdriven cancers[J]. Science, 2016, 353(6304): 1161-1165. DOI: 10.1126/science.aaf5171. |
[1] | 刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325. |
[2] | 杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337. |
[3] | 袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343. |
[4] | 陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349. |
[5] | 郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353. |
[6] | 张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358. |
[7] | 许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363. |
[8] | 王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369. |
[9] | 张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375. |
[10] | 高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381. |
[11] | 王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384. |
[12] | 刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273. |
[13] | 杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279. |
[14] | 王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285. |
[15] | 张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||